NBTY Not "Trigger Happy," But Acquisitions Stay In Its Crosshairs
This article was originally published in The Tan Sheet
Executive Summary
NBTY hopes to remain a supplement industry giant in part by continuing to acquire other businesses, a strategy with an improving outlook as opportunities emerge during the global economic slump
You may also be interested in...
NBTY Prefers Strategic Over "Easy" Acquisitions, Looks To China
NBTY looks to continue making strategic rather than "easy" acquisitions and includes China in its target markets, President Harvey Kamil says
NBTY Cites Lower Margins As The Cost Of Higher Private-Label Sales
Dietary supplement manufacturer NBTY's gross margins are unlikely to exceed 50 percent again largely because private-label product sales have nearly doubled since its acquisition of Leiner Health Products
NBTY's Julian Graves acquisition clears
U.K. regulators July 22 clear supplement firm NBTY's acquisition of 350-store U.K. confectionery chain Julian Graves. The OK followed provisional findings by the Competition Commission, the Ronkonkoma, N.Y.-based firm said. The firm purchased Julian Graves in September for $25 million, but the commission raised concerns the acquisition could obstruct competition in the market for seeds, nuts and dried fruit (1"The Tan Sheet" July 20, 2009). NBTY said it expects the commission to make a final decision before Sept. 4